» Authors » Malgorzata Popiel

Malgorzata Popiel

Explore the profile of Malgorzata Popiel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 92
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wilski M, Wnuk M, Brola W, Szczesniak M, Zak M, Sobolewski P, et al.
Front Psychiatry . 2024 Jan; 14:1352021. PMID: 38274416
Introduction: The complexity of the associations between religiosity and indicators of well-being suggests the presence of a mediating mechanism. Previous studies indicate that religion may influence subjective well-being because it...
2.
Podlecka-Pietowska A, Sierdzinski J, Nojszewska M, Stawicki J, Bartosik-Psujek H, Lech B, et al.
Neurol Neurochir Pol . 2024 Jan; 58(1):112-119. PMID: 38251955
Clinical Rationale For The Study: The rapid spread of SARS-CoV-2 throughout the world has highlighted the importance of vaccinations to control the pandemic and to protect people at risk for...
3.
Popiel M, Bartosik-Psujek H
Neurol Neurochir Pol . 2023 Dec; 58(1):84-93. PMID: 38112646
Aim Of The Study: To evaluate the clinical and radiological consequences of delayed escalation of therapy in patients with relapsing-remitting multiple sclerosis (RRMS), in whom, despite finding platform therapy ineffective,...
4.
Brola W, Szczesniak M, Wilski M, Zak M, Sobolewski P, Wnuk M, et al.
Neurol Neurochir Pol . 2023 Nov; 57(6):484-491. PMID: 38009502
Introduction: Happiness is crucial to patient well-being and their acceptance of their disease. The aim of this study was to assess the sense of happiness in persons with multiple sclerosis...
5.
Warmbier W, Popiel M, Guzik A, Druzbicki M, Bartosik-Psujek H
Front Neurol . 2023 Aug; 14:1225754. PMID: 37621859
Purpose: To assess dysarthric disorders in multiple sclerosis (MS) patients in comparison with healthy individuals and MS patients without dysarthria depending on the patient's sex, age, and the type of...
6.
Czarnowska A, Tarasiuk J, Zajkowska O, Wnuk M, Marona M, Nowak K, et al.
Front Neurol . 2022 Jul; 13:913283. PMID: 35775049
Background And Objectives: Since vaccination against COVID-19 is available for over a year and the population of immunized individuals with autoimmune disorders is higher than several months before, an evaluation...
7.
Czarnowska A, Tarasiuk J, Zajkowska O, Wnuk M, Marona M, Nowak K, et al.
Vaccines (Basel) . 2022 May; 10(5). PMID: 35632519
(1) Background: The present study aims to report the side effects of vaccination against coronavirus disease 2019 (COVID-19) among patients with multiple sclerosis (MS) who were being treated with disease-modifying...
8.
Czarnowska A, Kapica-Topczewska K, Zajkowska O, Adamczyk-Sowa M, Kubicka-Baczyk K, Niedziela N, et al.
J Clin Med . 2021 Nov; 10(22). PMID: 34830507
(1) Background: To report and analyze the presence of residual symptoms after SARS-CoV-2 infection among Polish patients with multiple sclerosis (MS) treated with different disease-modifying therapies (DMTs). (2) Methods: The...
9.
Czarnowska A, Brola W, Zajkowska O, Rusek S, Adamczyk-Sowa M, Kubicka-Baczyk K, et al.
Neurol Neurochir Pol . 2021 Apr; 55(2):212-222. PMID: 33856686
Introduction: The aim of this study was to report the course and outcome of SARS-CoV-2 infection in multiple sclerosis (MS) patients treated with disease-modifying therapies (DMTs) in Poland. A major...
10.
Popiel M, Psujek M, Bartosik-Psujek H
Mult Scler Relat Disord . 2018 Sep; 26:204-206. PMID: 30268042
Background: Certain disease-modifying drugs for multiple sclerosis are known to be ineffective in treating neuromyelitis optica spectrum disorder (NMOSD), and can even induce subsequent relapses. Case Presentation: Here, we report...